Helsinki University Central Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2016

  1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

2014

  1. DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

    Clinical Infectious Diseases, Vol. 58, Núm. 8, pp. 1072-1083

  2. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 423-430